IL172036A0 - Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window - Google Patents

Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window

Info

Publication number
IL172036A0
IL172036A0 IL172036A IL17203605A IL172036A0 IL 172036 A0 IL172036 A0 IL 172036A0 IL 172036 A IL172036 A IL 172036A IL 17203605 A IL17203605 A IL 17203605A IL 172036 A0 IL172036 A0 IL 172036A0
Authority
IL
Israel
Prior art keywords
restoration
organs
enhancement
tissues
protection
Prior art date
Application number
IL172036A
Original Assignee
Kenneth S Warren Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/015733 external-priority patent/WO2004112693A2/en
Application filed by Kenneth S Warren Inst Inc filed Critical Kenneth S Warren Inst Inc
Publication of IL172036A0 publication Critical patent/IL172036A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL172036A 2004-05-19 2005-11-17 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window IL172036A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2004/015733 WO2004112693A2 (en) 2003-05-19 2004-05-19 Tissue protective cytokines with an extended therapeutic window
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Publications (1)

Publication Number Publication Date
IL172036A0 true IL172036A0 (en) 2009-02-11

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
IL172036A IL172036A0 (en) 2004-05-19 2005-11-17 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window

Country Status (7)

Country Link
CN (1) CN1897960A (en)
AU (1) AU2004319797A1 (en)
BR (1) BRPI0412869A (en)
IL (1) IL172036A0 (en)
IS (1) IS8222A (en)
NO (1) NO20062506L (en)
WO (1) WO2005117927A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (en) * 2017-10-10 2019-04-18 Augustinus Bader Erythropoietin (epo) application in spinal cord injury (sci) therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
NZ542092A (en) * 2003-03-27 2008-04-30 Janssen Pharmaceutica Nv Use of erythropoietin (EPO) in stroke recovery wherein the EPO is formulated for administration for a particular dosage regime

Also Published As

Publication number Publication date
BRPI0412869A (en) 2006-10-03
WO2005117927A3 (en) 2006-05-11
AU2004319797A1 (en) 2006-01-12
NO20062506L (en) 2006-05-31
AU2004319797A8 (en) 2008-12-11
IS8222A (en) 2006-01-10
CN1897960A (en) 2007-01-17
WO2005117927A2 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
IL172035A0 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
EP1575528A4 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
PL374580A1 (en) Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
IL178142A0 (en) Methods of using and compositions comprising immunomodulatory compounos for the treatment and management of skin diseases or disorders
IL239695A0 (en) Tissue protective peptides and uses thereof
WO2006003094A3 (en) Merocyanine derivatives
IL166475A (en) Use of glutamine or carbohydrate in the manufacture of a composition for protecting non-mucosal tissue against damage from radiation therapy
IL192198A0 (en) Skin care compositions and treatments
HK1110508A1 (en) Compositions and methods of their use for improving the condition and appearance of skin
MX301561B (en) Use of transmission dyes for protecting human skin from browning and ageing
IL171501A (en) Genetically modified dermal micro-organs and use of the same
IL175462A0 (en) Ocular surgical protective shield
EP1758605A4 (en) Prouroguanylin as therapeutic and diagnostic agents
EP1736173A4 (en) Damaged tissue therapeutic agent and therapeutic method
WO2006062935A3 (en) Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin
EP1535514A4 (en) Composition for protecting organ, tissue or cell and utilization thereof
GB0420734D0 (en) Improvements in or relating to the therapeutic use of radiation and apparatus therefor
IL172036A0 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
WO2005084364A3 (en) Long acting tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
WO2007022140A3 (en) Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
EP1827494A4 (en) Combination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs
GB0508370D0 (en) Lotion for overall body and skin protection
WO2006000923A3 (en) Macrolide compositions as therapeutic agent
AU2004907069A0 (en) Therapeutic and diagnostic agents
GB0311291D0 (en) Composition and method for the protection of skin